{"id":"W3019934700","doi":"10.1111/apt.15716","title":"Letter: corticosteroid use alongside tofacitinib in OCTAVE Open. Authors' reply","year":2020,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; McMaster University; Population Health Research Institute","funders":"Pfizer","keywords":"Tofacitinib; Medicine; Octave (electronics); Open label; Corticosteroid; Dermatology; Surgery; Internal medicine; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001221497,0.0004943638,0.0009334081,0.0006346403,0.002383868,0.00174034,0.001327438,0.02870814,0.007943524],"category_scores_gemma":[0.01130419,0.0004337353,0.0009800536,0.000597003,0.001571948,0.003040913,0.0007994145,0.01897767,0.00549392],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002611979,"about_ca_system_score_gemma":0.001976168,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0037751,"about_ca_topic_score_gemma":0.004023984,"domain_scores_codex":[0.9990432,0.0002565132,0.0001245287,0.0001649358,0.0002445846,0.0001661576],"domain_scores_gemma":[0.9973864,0.001474022,0.0001637876,0.00007962069,0.0004247063,0.000471471],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001485036,0.00004779074,0.001741037,0.00005383736,0.00002106348,0.01593509,0.0001693658,0.0001216484,0.0002634617,0.001757264,0.9709636,0.008777308],"study_design_scores_gemma":[0.0003650766,0.0002820477,0.004050736,0.0006375382,0.00009514396,0.07025807,0.001178612,0.001656939,0.0009118447,0.01796339,0.9024027,0.0001978863],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.001325516,0.001499638,0.0001059317,0.9821668,0.01155749,0.00001335352,0.0001462791,0.00005819161,0.003126895],"genre_scores_gemma":[0.01375277,0.001370879,0.0002559282,0.9564042,0.02227733,0.00003658662,0.00009008763,0.00003827391,0.00577387],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.02870814,"threshold_uncertainty_score":0.02657372,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0444484926208937,"score_gpt":0.3122662275785071,"score_spread":0.2678177349576134,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}